ClinicalTrials.Veeva

Menu

Sensitivity Evaluation of Serological Tests for Covid-19 (COVIDIAGNOSTIX)

I

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Status

Unknown

Conditions

Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04678024
COVIDIAGNOSTIX

Details and patient eligibility

About

The primary objective of this study is to test the diagnostic sensitivity of antibody tests for the diagnosis of SARS-CoV2 infection, available to clinical laboratories, within a national network of hospitals carrying out research activities. Test the diagnostic specificity of antibody tests for the diagnosis of SARS-CoV2 infection. Complete a systematic evaluation of the different approaches. Perform Health technology Assessment (HITA) of the methodologies under study, in order to verify their reliability to the immunoglobulin levels produced by each individual exposed patient.

Enrollment

410 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

All patients or individuals exposed to Sars-Cov2 Infection.

Exclusion criteria

There are no criteria for excluding patients or individuals, if not the refusal to participate to project

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems